topoisomerase l

† These authors contributed equally to this work.
The Oncologist 1997;2:402-409 Clinical Use of Irinotecan: Current Status and Future Considerations
Tsao, Y. P., Russo, A., Nyamuswa, G., Silber, R. & Liu, L. F. Interaction between replication forks and topoisomerase I-DNA cleavabl...
Effects of antitumor compounds isolated from Pteris semipinnata L on DNA topoisomerases and cell cycle of HL-60 cells
Determination of DNA topoisomerase II activity from L1210 cells--a target for screening antitumor agents
Nuclear DNA Topoisomerases in Pisum sativum L.
Topoisomerase-I-Inhibitor mit potentiell strahlensensibilisierender Wirkung
Effect of active compounds isolated from Pteris Semipinnata L on DNA topoisomerases and tyrosine protein kinase and expression c myc...
Properties of a purified nuclear topoisomerase from L1210 cells
Topoisomerase II inhibitors from the roots of Stellera chamaejasme L.